817-71-0Relevant articles and documents
COMPLEMENT MODULATORS AND RELATED METHODS
-
Paragraph 0497, (2020/10/20)
The present disclosure presents compounds and compositions that interact with complement components. Some compounds inhibit complement activity. Included are small molecule compounds and compositions that function as C5 inhibitor compounds. Methods for inhibiting complement activity and methods of treating complement-related indications with the C5 inhibitor compounds and compositions are provided.
VISUAL CYCLE MODULATORS
-
Paragraph 00155, (2018/09/19)
A method of treating an ocular disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of a retinal sequestering compound of formula (I).
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
-
Page/Page column 129; 130, (2016/04/09)
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).